# A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001

> **NCT03126318** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 32 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** COR-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03126318
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-19
- **Primary completion:** 2019-03-14
- **Final completion:** 2019-12-19
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03126318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03126318, "A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03126318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*